The CDC made a strong recommendation based on a high certainty of evidence to use the long-acting injectable lenacapavir ...

Scientists say the drug stops the virus from replicating inside cells. The landmark deal to provide cheaper antiretroviral ...

Gilead's groundbreaking HIV prevention drug will soon be available at a fraction of its U.S. price in over 100 countries, ...

Indian drugmakers Dr Reddy's Laboratories and Hetero Labs said on Wednesday that they will sell generic versions of a new and ...

Yeztugo (lenacapavir) is an HIV-1 capsid inhibitor that is administered every 6 months after an initial dosing regimen.

Avoidable HIV infections and net health care costs would rise if coverage of pre-exposure prophylaxis (PrEP) were to be reduced even a moderate amount, according to a study published in JAMA Network ...

Stigma and lack of support hinder PrEP use among Black women; clinician bias and discrimination worsen disparities.

South Carolina Department of Public Health offering free HIV testing during PrEP Awareness Week September 22-26 ...

Advances in HIV medication, its window of detection and its transmission risk within the last decade have led to an updated ...

A new survey launched by Global Black Gay Men Connect is seeking responses from Black gay men and Black trans community ...

The South Carolina Department of Public Health (DPH) is observing its sixth annual PrEP (pre-exposure prophylaxis) Awareness ...